99mTc-glucarate imaging for the early detection of infarct in partially reperfused canine myocardium

Gerald Johnson, Christine C. Okada, Sonia D. Hocherman, Zhonglin Liu, Curtis Hart, Ban An Khaw, Robert D. Okada

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose: 99mTc-glucarate is an imaging agent developed for the detection of acutely infarcted myocardium. The purposes of the current study were to (1) determine whether 99mTc-glucarate can detect acute infarct in the setting of only partial minimal reperfusion, (2) study the persistence and time course of scan positivity following coronary occlusion and intravenous tracer injection, (3) assess the ability of 99mTc- glucarate to determine infarct size, and (4) compare these data with previous results obtained using a 100% reperfusion model. Methods: Six dogs underwent left circumflex (LCx) coronary occlusion for 90 min, followed by 10% epicardial blood flow reperfusion. Fifteen mCi (555 MBq) 99mTc-glucarate was injected intravenously 30 min later. Serial gamma camera images were acquired over 240 min. Microsphere blood flow determinations were performed at baseline, during occlusion, during tracer administration, and just before euthanasia. Ex vivo gamma camera images were obtained. Triphenyltetrazolium chloride (TTC) staining was performed to assess infarct size. Results: Qualitatively, 99mTc-glucarate images showed a well-defined "hot spot" in all six dogs by 30 min after tracer injection (150 min following coronary occlusion), which persisted for 240 min following tracer administration. Quantitatively, there was a significant increase in the LCx/LAD (left anterior descending) counts ratio beginning 10 min after tracer administration (130 min after occlusion), and continuing to 240 min after tracer administration. Tracer retention was 12.0±0.9% for the LAD and 39.0± 4.1% for the LCx hot spot zone (p<0.05) at 240 min after 99mTc-glucarate injection. The correlation coefficient was 0.90 for infarct size by TTC versus 99mTc-glucarate. Conclusion: In the setting of only partial minimal coronary reperfusion following infarction, 99mTc-glucarate myocardial uptake is delayed and less intense compared with the setting of complete reperfusion. Nevertheless, infarcts can still be reliably detected in dogs using qualitative in vivo imaging, and significant abnormalities in quantitative parameters are observed. Thus, 99mTc-glucarate imaging may be useful for the clinical detection and relative sizing of acute myocardial infarction, even in the setting of only minimal coronary reperfusion.

Original languageEnglish (US)
Pages (from-to)319-328
Number of pages10
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume33
Issue number3
DOIs
StatePublished - Mar 2006

Fingerprint

Canidae
Myocardium
Reperfusion
Coronary Occlusion
Myocardial Reperfusion
Gamma Cameras
Dogs
technetium Tc 99m glucarate
Injections
Euthanasia
Microspheres
Intravenous Injections
Infarction
Myocardial Infarction
Staining and Labeling

Keywords

  • Tc-glucarate
  • Imaging
  • Myocardial infarction
  • Radiotracer kinetics

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

99mTc-glucarate imaging for the early detection of infarct in partially reperfused canine myocardium. / Johnson, Gerald; Okada, Christine C.; Hocherman, Sonia D.; Liu, Zhonglin; Hart, Curtis; Khaw, Ban An; Okada, Robert D.

In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 33, No. 3, 03.2006, p. 319-328.

Research output: Contribution to journalArticle

Johnson, Gerald ; Okada, Christine C. ; Hocherman, Sonia D. ; Liu, Zhonglin ; Hart, Curtis ; Khaw, Ban An ; Okada, Robert D. / 99mTc-glucarate imaging for the early detection of infarct in partially reperfused canine myocardium. In: European Journal of Nuclear Medicine and Molecular Imaging. 2006 ; Vol. 33, No. 3. pp. 319-328.
@article{fc777e4c931445a391318bf13e41c150,
title = "99mTc-glucarate imaging for the early detection of infarct in partially reperfused canine myocardium",
abstract = "Purpose: 99mTc-glucarate is an imaging agent developed for the detection of acutely infarcted myocardium. The purposes of the current study were to (1) determine whether 99mTc-glucarate can detect acute infarct in the setting of only partial minimal reperfusion, (2) study the persistence and time course of scan positivity following coronary occlusion and intravenous tracer injection, (3) assess the ability of 99mTc- glucarate to determine infarct size, and (4) compare these data with previous results obtained using a 100{\%} reperfusion model. Methods: Six dogs underwent left circumflex (LCx) coronary occlusion for 90 min, followed by 10{\%} epicardial blood flow reperfusion. Fifteen mCi (555 MBq) 99mTc-glucarate was injected intravenously 30 min later. Serial gamma camera images were acquired over 240 min. Microsphere blood flow determinations were performed at baseline, during occlusion, during tracer administration, and just before euthanasia. Ex vivo gamma camera images were obtained. Triphenyltetrazolium chloride (TTC) staining was performed to assess infarct size. Results: Qualitatively, 99mTc-glucarate images showed a well-defined {"}hot spot{"} in all six dogs by 30 min after tracer injection (150 min following coronary occlusion), which persisted for 240 min following tracer administration. Quantitatively, there was a significant increase in the LCx/LAD (left anterior descending) counts ratio beginning 10 min after tracer administration (130 min after occlusion), and continuing to 240 min after tracer administration. Tracer retention was 12.0±0.9{\%} for the LAD and 39.0± 4.1{\%} for the LCx hot spot zone (p<0.05) at 240 min after 99mTc-glucarate injection. The correlation coefficient was 0.90 for infarct size by TTC versus 99mTc-glucarate. Conclusion: In the setting of only partial minimal coronary reperfusion following infarction, 99mTc-glucarate myocardial uptake is delayed and less intense compared with the setting of complete reperfusion. Nevertheless, infarcts can still be reliably detected in dogs using qualitative in vivo imaging, and significant abnormalities in quantitative parameters are observed. Thus, 99mTc-glucarate imaging may be useful for the clinical detection and relative sizing of acute myocardial infarction, even in the setting of only minimal coronary reperfusion.",
keywords = "Tc-glucarate, Imaging, Myocardial infarction, Radiotracer kinetics",
author = "Gerald Johnson and Okada, {Christine C.} and Hocherman, {Sonia D.} and Zhonglin Liu and Curtis Hart and Khaw, {Ban An} and Okada, {Robert D.}",
year = "2006",
month = "3",
doi = "10.1007/s00259-005-1913-x",
language = "English (US)",
volume = "33",
pages = "319--328",
journal = "European Journal of Nuclear Medicine and Molecular Imaging",
issn = "1619-7070",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - 99mTc-glucarate imaging for the early detection of infarct in partially reperfused canine myocardium

AU - Johnson, Gerald

AU - Okada, Christine C.

AU - Hocherman, Sonia D.

AU - Liu, Zhonglin

AU - Hart, Curtis

AU - Khaw, Ban An

AU - Okada, Robert D.

PY - 2006/3

Y1 - 2006/3

N2 - Purpose: 99mTc-glucarate is an imaging agent developed for the detection of acutely infarcted myocardium. The purposes of the current study were to (1) determine whether 99mTc-glucarate can detect acute infarct in the setting of only partial minimal reperfusion, (2) study the persistence and time course of scan positivity following coronary occlusion and intravenous tracer injection, (3) assess the ability of 99mTc- glucarate to determine infarct size, and (4) compare these data with previous results obtained using a 100% reperfusion model. Methods: Six dogs underwent left circumflex (LCx) coronary occlusion for 90 min, followed by 10% epicardial blood flow reperfusion. Fifteen mCi (555 MBq) 99mTc-glucarate was injected intravenously 30 min later. Serial gamma camera images were acquired over 240 min. Microsphere blood flow determinations were performed at baseline, during occlusion, during tracer administration, and just before euthanasia. Ex vivo gamma camera images were obtained. Triphenyltetrazolium chloride (TTC) staining was performed to assess infarct size. Results: Qualitatively, 99mTc-glucarate images showed a well-defined "hot spot" in all six dogs by 30 min after tracer injection (150 min following coronary occlusion), which persisted for 240 min following tracer administration. Quantitatively, there was a significant increase in the LCx/LAD (left anterior descending) counts ratio beginning 10 min after tracer administration (130 min after occlusion), and continuing to 240 min after tracer administration. Tracer retention was 12.0±0.9% for the LAD and 39.0± 4.1% for the LCx hot spot zone (p<0.05) at 240 min after 99mTc-glucarate injection. The correlation coefficient was 0.90 for infarct size by TTC versus 99mTc-glucarate. Conclusion: In the setting of only partial minimal coronary reperfusion following infarction, 99mTc-glucarate myocardial uptake is delayed and less intense compared with the setting of complete reperfusion. Nevertheless, infarcts can still be reliably detected in dogs using qualitative in vivo imaging, and significant abnormalities in quantitative parameters are observed. Thus, 99mTc-glucarate imaging may be useful for the clinical detection and relative sizing of acute myocardial infarction, even in the setting of only minimal coronary reperfusion.

AB - Purpose: 99mTc-glucarate is an imaging agent developed for the detection of acutely infarcted myocardium. The purposes of the current study were to (1) determine whether 99mTc-glucarate can detect acute infarct in the setting of only partial minimal reperfusion, (2) study the persistence and time course of scan positivity following coronary occlusion and intravenous tracer injection, (3) assess the ability of 99mTc- glucarate to determine infarct size, and (4) compare these data with previous results obtained using a 100% reperfusion model. Methods: Six dogs underwent left circumflex (LCx) coronary occlusion for 90 min, followed by 10% epicardial blood flow reperfusion. Fifteen mCi (555 MBq) 99mTc-glucarate was injected intravenously 30 min later. Serial gamma camera images were acquired over 240 min. Microsphere blood flow determinations were performed at baseline, during occlusion, during tracer administration, and just before euthanasia. Ex vivo gamma camera images were obtained. Triphenyltetrazolium chloride (TTC) staining was performed to assess infarct size. Results: Qualitatively, 99mTc-glucarate images showed a well-defined "hot spot" in all six dogs by 30 min after tracer injection (150 min following coronary occlusion), which persisted for 240 min following tracer administration. Quantitatively, there was a significant increase in the LCx/LAD (left anterior descending) counts ratio beginning 10 min after tracer administration (130 min after occlusion), and continuing to 240 min after tracer administration. Tracer retention was 12.0±0.9% for the LAD and 39.0± 4.1% for the LCx hot spot zone (p<0.05) at 240 min after 99mTc-glucarate injection. The correlation coefficient was 0.90 for infarct size by TTC versus 99mTc-glucarate. Conclusion: In the setting of only partial minimal coronary reperfusion following infarction, 99mTc-glucarate myocardial uptake is delayed and less intense compared with the setting of complete reperfusion. Nevertheless, infarcts can still be reliably detected in dogs using qualitative in vivo imaging, and significant abnormalities in quantitative parameters are observed. Thus, 99mTc-glucarate imaging may be useful for the clinical detection and relative sizing of acute myocardial infarction, even in the setting of only minimal coronary reperfusion.

KW - Tc-glucarate

KW - Imaging

KW - Myocardial infarction

KW - Radiotracer kinetics

UR - http://www.scopus.com/inward/record.url?scp=33644982573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644982573&partnerID=8YFLogxK

U2 - 10.1007/s00259-005-1913-x

DO - 10.1007/s00259-005-1913-x

M3 - Article

C2 - 16237571

AN - SCOPUS:33644982573

VL - 33

SP - 319

EP - 328

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

SN - 1619-7070

IS - 3

ER -